Analystreport

Atossa Therapeutics, Inc. (NASDAQ: ATOS) had its price target lowered by analysts at Ascendiant Capital Markets to $7.00.

Atossa Therapeutics, Inc.  (ATOS) 
Last atossa therapeutics, inc. earnings: 11/13 04:10 pm Check Earnings Report
US:NASDAQ Investor Relations: ir.atossagenetics.com